Shasun Pharmaceuticals Ltd(Merged)

Next 500 2015
OVERVIEW
FINANCIALS

Featured In Fortune India Ranking

Next 500 India
#160(2015)
#160(2015)

Financial Data 2015

Revenue
1,339
(INR Cr)
Net Operating Income
1,317
(INR Cr)
Assets
1,124
(INR Cr)
Profit
24
(INR Cr)
Net Worth
379
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2015201420132012201120102009
Revenue
(INR Cr)
1339
6.8%
1253
11.6%
1124
1.3%
1110
25.8%
882
9.2%
808
5.5%
766
-
Net Operating Income
(INR Cr)
1317
8.57%
1213
11.79%
1085
1.72%
1066
27.80%
834
6.42%
784
4.43%
751
-7.19%
Profit
(INR Cr)
24
-21.4%
30
-43.0%
53
-47.3%
101
277.8%
27
606.1%
4
-
-137
-
Assets
(INR Cr)
1124
12.5%
1000
27.6%
783
34.9%
581
35.4%
429
-3.5%
444
-0.1%
445
-
Net Worth
(INR Cr)
379
25.2%
303
11.2%
272
22.4%
222
164.9%
84
-28.8%
118
10.8%
106
-55.6%
Employee Cost
(INR Cr)
236
9.3%
216
15.9%
187
17.1%
159
11.3%
143
2.2%
140
-18.5%
172
-
Interest Cost
(INR Cr)
63503244323022
Cash & Bank Balance
(INR Cr)
31361412158
Total Debt
(INR Cr)
739692506353329327339

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2015201420132012201120102009
Profit As % Of Revenues 1.8%2.4%4.7%9.1%3.0%0.5%-
Profit As % Of Assets 2.1%3.0%6.8%17.3%6.2%0.9%-
Profit As % Of Networth 6.3%10.0%19.5%45.2%31.7%3.2%-
Interest Cost to EBITDA % 54.3%45.6%27.5%35.5%45.1%98.2%-
Debt to Equity Ratio 1.952.291.861.593.922.773.18
RONW 5.9%10.5%21.5%46.4%25.5%-10.5%-
ROCE 7.9%8.2%12.1%18.8%12.7%3.3%-25.3%